MP402IMPROVEMENT OF PHYSICAL DECLINE THROUGH COMBINED EFFECTS OF MUSCLE ENHANCEMENT AND MITOCHONDRIAL ACTIVATION BY A GASTRIC HORMONE GHRELIN IN MALE 5/6NX CKD MODEL MICE

Authors:

Abstract
Introduction and Aims: Chronic kidney disease (CKD) impairs physical performance. A physical decline correlates with an increased risk of a wide range of disease and morbidity. The principal cause of physical decline has been regarded as a decrease in muscle mass. However, our recent study showed that a decrease in muscle mitochondria plays a critical role, associated with a reduction in the expression of muster regulator of mitochondrial biogenesis, peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α). Recently, a DNA methylation of the cytosine residue at 260 base pairs upstream (C-260) of initiation point of the PGC-1α gene was demonstrated to significantly decrease the gene expression. Ghrelin, a gastric hormone, treatment was reported to increase muscle mass and promote muscle mitochondrial oxidation. In the present study, we examined the usefulness of ghrelin treatment for a recovery of physical decline in 5/6 nephrectomized (5/6Nx) CKD model mice, in comparison with IGF-1 treatment.